Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Sirtuin activation targets IDH-mutant tumors

Neuro-Oncology(2020)10.1093/neuonc/noaa180Source: DataRank Database

Sirtuin activation targets IDH-mutant tumors is a research paper published in Neuro-Oncology (2020). On theSindex it has a DataRank of 0. It has been cited 31 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access31 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.77)OA: bronzeTopics (32)Linked Datasets (8)DataCite Reuse (8)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Alexandria L. Fink,Jack A Banagis,Hiroaki Nagashima ORCID,Megha Subramanian ORCID,Christine K. Lee ORCID

Live enrichment

PubMed:32710757 PMC:PMC7850026 OpenAlex:https://openalex.org/W3044762204

National Institutes of Health

Grant: R01CA227821

National Institutes of Health

Grant: P50CA165962

NCI NIH HHS

Grant: K12 CA090354

FWCI

1.77

Citation Percentile

0.8%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model

journalhttps://academic.oup.com/neuro-oncology/article-pdf/23/1/53/36153803/noaa180.pdf

publisherhttps://academic.oup.com/neuro-oncology/article-pdf/23/1/53/36153803/noaa180.pdf

publisherhttp://academic.oup.com/neuro-oncology/advance-article-pdf/doi/10.1093/neuonc/noaa180/33689755/noaa180.pdf

publisherhttp://academic.oup.com/neuro-oncology/article-pdf/23/1/53/36153803/noaa180.pdf

journalhttps://doi.org/10.1093/neuonc/noaa180

Fields of Study

Sirtuins and Resveratrol in MedicineBiochemical and Molecular ResearchPARP inhibition in cancer therapy

MeSH Terms

GliomaHumansIsocitrate DehydrogenaseNADCytokinesSirtuinsSirtuin 1

Keywords

NAD+ kinaseNicotinamide phosphoribosyltransferaseIsocitrate dehydrogenaseNicotinamide adenine dinucleotideMutantSirtuinSirtuin 1BiologyIDH1CofactorCancer researchBiochemistryEnzymeMolecular biologyChemistryCell biologyGeneDownregulation and upregulationGliomaIdhNad+Nampt

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of CCL3 secreted by hepatocytes promotes the metastasis of intrahepatic cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (m6A) modification

10.6084/m9.figshare.26563492.v1figshare

Additional file 1 of CCL3 secreted by hepatocytes promotes the metastasis of intrahepatic cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (m6A) modification

10.6084/m9.figshare.26563492figshare

Additional file 2 of CCL3 secreted by hepatocytes promotes the metastasis of intrahepatic cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (m6A) modification

10.6084/m9.figshare.26563495.v1figshare

Additional file 2 of CCL3 secreted by hepatocytes promotes the metastasis of intrahepatic cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (m6A) modification

10.6084/m9.figshare.26563495figshare

Additional file 3 of CCL3 secreted by hepatocytes promotes the metastasis of intrahepatic cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (m6A) modification

10.6084/m9.figshare.26563498.v1figshare

Additional file 3 of CCL3 secreted by hepatocytes promotes the metastasis of intrahepatic cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (m6A) modification

10.6084/m9.figshare.26563498figshare

Additional file 4 of CCL3 secreted by hepatocytes promotes the metastasis of intrahepatic cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (m6A) modification

10.6084/m9.figshare.26563501.v1figshare

Additional file 4 of CCL3 secreted by hepatocytes promotes the metastasis of intrahepatic cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (m6A) modification

10.6084/m9.figshare.26563501figshare